Microcaps’ new technology makes microencapsulation, widely used in pharmaceuticals, food and fragrances, 1,000-times faster than the current-state-of-the art. Oxyprem’s device will reduce death and brain-damage in preterm babies. Both get CHF130’000 from Venture Kick.